Refine by
Cardiac Electrical Articles & Analysis
10 news found
Corify Care today announced a clinical milestone with two studies published in Heart Rhythm and Europace, validating its 4-D global cardiac mapping technology for atrial and ventricular arrhythmias in a single beat.Compared with conventional mapping, which often requires rhythm induction or dependence on pre-procedural imaging, the ACORYS mapping system captures global ...
Food and Drug Administration (FDA) has granted clearance for the ACORYS® System, the first imageless, non-invasive cardiac mapping platform capable of delivering a global, four-chamber view of cardiac electrical activity in real time.The milestone represents a fundamental shift in electrophysiology by combining high-resolution 3D anatomical ...
MADRID, Spain – March 2026 – Corify Care announces ATENEA, a project introducing real-time Digital Twin technology to the electrophysiology laboratory, enabling clinicians to simulate and optimize ablation strategies before intervention.ATENEA represents Phase 2 of the Corify platform, focusing on AI-driven Digital Twin development to assist electrophysiologists in diagnosing and treating complex ...
CCM therapy has been pioneered by Impulse Dynamics to significantly improve heart contraction, allowing more oxygen-rich blood to be pushed throughout the body.[1] The Optimizer delivers precisely timed electrical pulses to the heart during the absolute refractory period of the beating cycle, immediately after the heart contracts. ...
When informed about the FDA’s approval regarding the removal of NSR, Dr. George Mark, a clinical cardiac electrophysiologist with The Heart House in Marlton, N.J., stated that “CCM is an important therapeutic option appropriate for patients who manifest lifestyle limiting symptoms despite guideline-directed medical therapy (GDMT) for congestive heart failure (CHF). ...
The funds are being used to advance the development of Galaxy’s flagship product CENTAURI™, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias. “Pulsed electric field ablation is a game-changing intervention in cardiac arrhythmias, and the Galaxy CENTAURI system has distinct ...
CCM therapy delivers precisely timed electrical pulses to the heart during the absolute refractory period of the beating cycle, just after the heart contracts. ...
” About the Optimizer® and CCM® Therapy CCM® is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device to improve systolic contraction of the heart. ...
MENLO PARK, California, October 9, 2020 — Galaxy Medical, (Galaxy), a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients were successfully treated with the proprietary CENTAURI™ System by Dr. ...
Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator and catheters – is ...